| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-762-50 | 62135-762 | HUMAN PRESCRIPTION DRUG | Methylprednisolone | Methylprednisolone | TABLET | ORAL | 20240514 | N/A | ANDA | ANDA209097 | Chartwell RX, LLC | METHYLPREDNISOLONE | 16 mg/1 | 50 TABLET in 1 BOTTLE (62135-762-50) |
| 62135-760-01 | 62135-760 | HUMAN PRESCRIPTION DRUG | Methylprednisolone | Methylprednisolone | TABLET | ORAL | 20240514 | N/A | ANDA | ANDA209097 | Chartwell RX, LLC | METHYLPREDNISOLONE | 4 mg/1 | 100 TABLET in 1 BOTTLE (62135-760-01) |
| 62135-760-21 | 62135-760 | HUMAN PRESCRIPTION DRUG | Methylprednisolone | Methylprednisolone | TABLET | ORAL | 20240514 | N/A | ANDA | ANDA209097 | Chartwell RX, LLC | METHYLPREDNISOLONE | 4 mg/1 | 21 TABLET in 1 BOTTLE (62135-760-21) |
| 62135-759-30 | 62135-759 | HUMAN PRESCRIPTION DRUG | Methylprednisolone | Methylprednisolone | TABLET | ORAL | 20240514 | N/A | ANDA | ANDA209097 | Chartwell RX, LLC | METHYLPREDNISOLONE | 2 mg/1 | 30 TABLET in 1 BOTTLE (62135-759-30) |
| 62135-763-26 | 62135-763 | HUMAN PRESCRIPTION DRUG | Methylprednisolone | Methylprednisolone | TABLET | ORAL | 20240514 | N/A | ANDA | ANDA209097 | Chartwell RX, LLC | METHYLPREDNISOLONE | 32 mg/1 | 25 TABLET in 1 BOTTLE (62135-763-26) |
| 62135-761-26 | 62135-761 | HUMAN PRESCRIPTION DRUG | Methylprednisolone | Methylprednisolone | TABLET | ORAL | 20240514 | N/A | ANDA | ANDA209097 | Chartwell RX, LLC | METHYLPREDNISOLONE | 8 mg/1 | 25 TABLET in 1 BOTTLE (62135-761-26) |